血管导管相关血流感染预防与控制最佳证据实施现状调查
作者:
作者单位:

1.湖南中医药大学护理学院;2.长沙市中心医院 南华大学附属长沙中心医院护理部;3.湖南省人民医院 湖南师范大学附属第一医院护理部

作者简介:

通讯作者:

吴传芳  E-mail: 465385022@qq.com

中图分类号:

R197.323.4

基金项目:

湖南省自然科学基金科卫联合项目(2019JJ80052);湖南省卫生健康委临床医学研究一般项目(20201976);2022年长沙市中心医院(南华大学附属长沙中心医院)重点项目(YNKY202212)


Implementation situation of best evidence practice for prevention and control of vascular catheter-related bloodstream infection
Author:
Affiliation:

1.School of Nursing, Hunan University of Chinese Medicine, Changsha 410208, China;2.Department of Nursing, Changsha Central Hospital, Affiliated to University of South China, Changsha 410004, China;3.Department of Nursing, Hunan Provincial People's Hospital [The First Affiliated Hospital of Hunan Normal University], Changsha 410002, China

Fund Project:

  • 摘要
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 文章评论
    摘要:

    目的 了解某省二级及以上医疗机构导管相关血流感染(CRBSI)预防与控制实施现状,为医疗机构采取有效措施落实最佳证据,降低CRBSI提供参考依据。 方法 依据《血管导管相关感染预防与控制指南(2021版)》自行设计调查问卷,于2021年7月对某省二级及以上医疗机构CRBSI防控现状进行调查。 结果 共回收问卷87份,有效问卷79份,有效回收率90.8%。79所医疗机构的CRBSI监测工作(89.9%)和防控制度的制定(94.9%)基本落实,但制度更新滞后,仅78.7%予以更新。68.4%的医院关注了本院近3年的CRBSI发病率,关注中心静脉导管(CVC)、经外周静脉置入中心静脉导管(PICC)、透析导管相关感染发病率的医院较少,最低仅占38.9%。置管前评估(100%)和置管时置管者无菌操作技术(≥97.5%) 落实较好。CRBSI防控指南落实的四个薄弱环节:仅有3.8%的医院选用含洗必泰醇浓度>0.5%的消毒剂进行皮肤消毒,54.4%的医院紧急状态下置管不能保证有效无菌操作技术时未在2 d内拔管,43.0%的医院存在病房内置管现象,43.0%的医院在使用导管输血后未在4 h内更换附加装置;26.6%的医院表明重症监护病房(ICU)是CRBSI发病率最高的科室。 结论 目前临床上CRBSI防控措施的落实与指南有一定差距,建议医务人员加强对最佳实践标准的认识,切实遵照指南落实感染防控工作,最大限度降低CRBSI的风险。

    Abstract:

    Objective To understand the implementation situation of prevention and control of catheter-related bloodstream infection (CRBSI) in second-level and above medical institutions in a province, so as to provide refe-rence for medical institutions to take effective measures to implement the best evidence and reduce CRBSI. Methods Questionnaire was designed base on Guideline for prevention and control of vascular catheter-related infection (2021 version), current situation of prevention and control of CRBSI in second-level and above medical institutions in a province in July 2021 was investigated. Results A total of 87 questionnaires were collected and 79 (90.8%) were available. Monitoring work (89.9%) as well as formulation of prevention and control system (94.9%) for CRBSI in 79 medical institutions were basically implemented, but the system update was lagging behind, only 78.7% of them were updated. 68.4% of the hospitals paid attention to the incidence of CRBSI in the past three years, and few hospitals paid attention to the incidence of central venous catheter (CVC), peripherally-inserted central venous catheter (PICC) and dialysis catheter-related infection, with the lowest rate of 38.9%. Pre-catheterization evaluation (100%) and sterile manipulation technology of operator during catheterization (≥97.5%) were well implemented. There were four weak points in the implementation of CRBSI prevention and control guidelines: only 3.8% of hospitals used disinfectant containing chlorhexidine concentration >0.5% for skin disinfection, 54.4% of hospitals failed to pull out catheter within 2 days when emergency catheterization could not ensure effective aseptic operation technique, 43.0% of hospitals performed catheterization in wards, and 43.0% of hospitals failed to replace additional devices within 4 hours after using catheter blood transfusion; 26.6% of hospitals indicated that intensive care unit was the department with the highest incidence of CRBSI. Conclusion At present, there is a certain gap between the implementation of prevention and control measures for CRBSI in clinical practice and the guidelines, it is recommended that medical personnel strengthen their understanding of the best practice standards, implement infection prevention and control in accordance with the guidelines, and minimize the risk of CRBSI.

    参考文献
    相似文献
引用本文

戴凡,吴传芳,谭创,等.血管导管相关血流感染预防与控制最佳证据实施现状调查[J]. 中国感染控制杂志,2022,(8):774-780. DOI:10.12138/j. issn.1671-9638.20222673.
Fan DAI, Chuan-fang WU, Chuang TAN, et al. Implementation situation of best evidence practice for prevention and control of vascular catheter-related bloodstream infection[J]. Chin J Infect Control, 2022,(8):774-780. DOI:10.12138/j. issn.1671-9638.20222673.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-03-21
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-09-02
  • 出版日期: